Dataset opportunity
Francismedical — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Francismedical, usable for Diagnostic AI and Computer Vision.
Score
70
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in medical imaging market = $1.88 billion in 2025, CAGR 36.91%.
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-11-12
J&J leads Francis Medical investment to fund prostate cancer device
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- ✨Signal
ClinicalTrials.gov: Vanquish Water Vapor Ablation for Prostate Cancer
source ↗
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Francismedical holds a unique Medical Imaging Dataset, which includes a rich `image_collection` combined with `iot_data` and `medical_records`. This multi-modal composition makes it exceptionally well-suited for developing and validating high-performance Diagnostic AI models. The data's origin from the ongoing Vanquish Study clinical trial ensures high-quality, structured, and longitudinally-relevant information, a rare asset for AI developers.
This dataset serves the global AI in medical imaging market, which was valued at $1.88 billion in 2025 and is projected to grow at a 36.91% CAGR. While access is subject to negotiation due to HIPAA and GDPR regulations and requires IRB approval for secondary use, its direct link to ongoing clinical trials makes it an exceptionally valuable resource, justifying the investment for buyers aiming to lead in this high-growth market. ⚠ Diligence (valuable data, access to negotiate): Medical data subject to HIPAA and GDPR regulations.; Data is tied to ongoing clinical trials (Vanquish Study).; Requires de-identification and IRB approval for secondary use. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Francismedical owns a proprietary, multi-modal dataset from a prostate cancer clinical trial, uniquely combining longitudinal MRI and ultrasound images with corresponding procedural time-series data. This is a rare and complete asset for medical AI companies developing next-generation diagnostic AI for treatment monitoring and outcome prediction. In a medical imaging AI market projected to grow at nearly 37% annually, this dataset offers a significant competitive advantage in the high-value oncology space.
See dimension details ↓- Dataset Specificity90
dominant 'medical_records', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
Buyer demand is exceptionally high, driven by the explosive growth of the AI in medical imaging market, which is expanding at a 36.91% CAGR.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=company_owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 data-appetite signals (1 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 1 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — Francis Medical is an ideal target as it's a pre-revenue SME whose core business is developing and selling a medical device, generating valuable clinical trial data as a by-product that it does not currently monetize.
- Deep Qualification90
✓ pass — Francis Medical is a medical device company, and the data from its VAPOR 2 clinical trial, including MRI images, is a valuable byproduct of its R&D and regulatory activities, making it a strong data holder candidate.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Medical records / imaging
The evidence confirms the existence of structured data from a formal clinical trial (VAPOR 2), providing the essential patient and procedural context required by AI developers to validate diagnostic models for prostate cancer.
IoT / sensor data
The dataset includes proprietary time-series data from the medical device, capturing procedural details like thermal energy delivery, which is highly valuable for developing AI that predicts treatment efficacy.
Image collection
The collection contains high-value, longitudinal MRI and ultrasound images, providing the pre- and post-operative data essential for training diagnostic AI to monitor treatment zones and predict oncological outcomes.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Francismedical Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in medical imaging market = $1.88 billion in 2025, CAGR 36.91% (source: Fortune Business Insights).. Investment score 70.0/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Bridgetolife — Medical Imaging Dataset Opportunity
View opportunity →healthcareAdipogen — Industrial Operations Dataset Opportunity
View opportunity →healthcareElevationspine — Medical Imaging Dataset Opportunity
View opportunity →Data Academy
Learn before you deal
- How a Data Transaction Works3 min read
- What you are entitled to sell3 min read
- 5 Mistakes That Drive Buyers Away3 min read